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Abstract: 
Permeabilization of the Endoplasmic Reticulum (ER) is instrumental in the progression 
of host-cell infection by many viral pathogens. We have described that permeabilization 
of ER model membranes by the pore-forming domain of the Classical Swine Fever 
Virus (CSFV) p7 protein depends on two sequence determinants: the C-terminal 
transmembrane helix, and the preceding polar loop that regulates its activity. Here, by 
combining ion-channel activity measurements in planar lipid bilayers with imaging of 
single Giant Unilamellar Vesicles (GUVs), we demonstrate that point substitutions 
directed to conserved residues within these regions affect ER-like membrane 
permeabilization following distinct mechanisms. Whereas the polar loop appeared to be 
involved in protein insertion and oligomerization, substitution of residues predicted to 
face the lumen of the pore inhibited large conducting channels (> 1nS) over smaller ones 
(120 pS). Quantitative analyses of the ER-GUV distribution as a function of the solute 
size revealed a selective inhibition for the permeation of solutes with sizes larger than 4 
kDa, further demonstrating that the mutation targeting the transmembrane helix 
prevented formation of the large pores. Collectively, our data support the idea that the 
pore-forming domain of p7 may assemble into finite pores with approximate diameters 
of 1 and 5 nm. Moreover, the observation that the mutation interfering with formation of 
the larger pores can hamper virus production without affecting ER localization or homo-
oligomerization, suggests prospective strategies to block/attenuate pestiviruses.  
 
Key words:  pore-forming peptide; membrane permeabilization; ion channel; ER 
membrane; peptide-lipid interaction 
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1. Introduction 
Unregulated pore formation in cell membranes results in the alteration of the ionic 
homeostasis, the loss of electrochemical gradients and ultimately cell death. Secreted 
pore-forming proteins or peptides targeting membranes constitute molecular weapons 
produced by organisms of diverse origin, and are also part of ancestral immune 
systems, which are functional in defending against pathogen invasion [1-6]. Membrane 
specificity of pore formation can be in addition exploited as the basis for antibiotic and 
anti-cancer drug development [7-9]. Thus, unravelling the molecular mechanisms that 
sustain the formation of permeating pores and govern their functioning in lipid bilayers 
remains a highly relevant research issue [3, 10-13]. 
Poration of the plasma membrane and the different components of the 
endomembrane system is also a significant issue in the cell infection cycle of many 
viruses. Formation by virally encoded pore-forming proteins (designated as 
“viroporins”[14]), of poorly-selective, ion-conductive channels has been proved 
instrumental in uncoating, transport and maturation of viral particles, but can also 
influence spread and pathogenicity [15, 16]. A conspicuous organelle targeted by 
viroporins is the Endoplasmic Reticulum (ER) [17]. Besides its taking part in the 
different stages of viral replication and assembly, permeabilization of this organelle can 
modulate several viral functions and plays an important role in host cell-death [15, 17]. 
Thus, ER permeabilization by pore-forming viral products is a biologically relevant 
phenomenon, but studies addressing the mechanisms of pore formation in ER model 
membranes are to a great extent missing.  
To address this issue, we have recently modelled the ER permeabilization 
phenomenon combining: (i) membranes that emulated the ER lipid composition; and 
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(ii) the pore-forming domain of the Classical Swine Fever Virus (CSFV) p7 product 
[18-20]. In the one hand, even though the ER is the main site of synthesis of sterols and 
complex sphingolipids, the ER membrane displays only low concentrations of these 
lipid species at localized sites [21]. Accordingly, the overall ER membrane can be fairly 
modelled by a combination of its main constituent phospholipids: zwitterionic PC and 
PE plus the anionic PI mixed in a roughly 5:3:2 molar ratio [21]. On the other hand, 
CSFV p7 is a small, hydrophobic protein of approximately 60-70 amino acids, which 
displays membrane-porating activity and forms homo-oligomers that mainly localize to 
the ER [15, 18, 19, 22]. Large Unilamellar vesicle (LUV) permeability assays mapped 
the p7 porating domain to its C-terminal transmembrane helix, while the addition of the 
preceding polar segment conferred pH dependence and sensitivity to channel blockers 
[19]. These observations were further supported by functional measurements of ion-
conducting channel (IC) activity in ER-like planar lipid membranes [20], which 
confirmed that a sequence combining the polar segment and the C-terminal helix, 
designated as p7C, comprises the pore-forming domain of the protein.  
Here, to gain insights into the mechanisms underlying ER permeabilization by viral 
products and its potential relation to virulence, we have focused on the effect of point 
mutations involving strictly conserved residues within the cytosolic loop and 
transmembrane helix of CSFV p7C [18]. We have followed an unprecedented 
combined approach to analyze pore formation, namely, IC activity measurements in 
planar bilayers and determination of the permeabilization degrees of individual vesicles 
by fluorescence microscopy imaging. Our combinational approach provided evidence 
sustaining the formation in ER-like membranes of two types of p7C pores with 
approximate diameters of 1 and 5 nm. Moreover, the observation that a mutation 
favoring the small pores hampered virus production without affecting ER localization, 
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points to the large pore structures as potential targets for blocking pestivirus 
propagation and pathogenicity. 
 
2.Materials and Methods 
2.1 Materials – Synthetic peptides p7C-wt, p7C-FH, and p7C-KK (sequences 
displayed in Fig 1A) were produced as previously described [18, 19]. 
Phosphatidylcholine (PC), phospahtidylethanolamine (PE), phospahtidylethanolamine-
N-(lissamine rhodamine B sulfonyl) (Rho-PE), and phosphatidylinositol (PI) were 
purchased from Avanti Polar Lipids (Birmingham, AL, USA). The 8-aminonaphtalene-
1,3,6-trisulfonic acid sodium salt (ANTS), p-xylenebis(pyridinium)bromide (DPX), 
phenol 4-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1H-benzimidazol]-2'-yl]- trihydrochloride 
(Hoechst 33258), and Alexa Fluor 488  were obtained from Molecular Probes (Junction 
City, OR, USA). Rabbit polyclonal antibody against GFP (FL) conjugated with 
horseradish peroxidase (HRP) was obtained from Santa Cruz Biotechnology (Dallas, 
TX, USA). Plasmid containing mCh-Sec61 beta was a gift from Gia Voeltz (Addgene 
plasmid # 49155) [23]. 
2.2 Monolayer penetration assays – Penetration into lipid monolayers was measured 
to compare the capacity of p7 peptides for inserting into membranes that mimic the ER 
[19]. In brief, maximal changes in surface pressure were monitored as a function of 
initial surface pressure (π0) in a fixed-area circular trough (μTrough S system, Kibron, 
Helsinki) measuring 2 cm in diameter and with a volume of 1.25 ml. The aqueous phase 
consisted of 1 ml of 5 mM NaOAc, 100 mM NaCl (pH 5.0). Lipids, dissolved in 
chloroform, were spread over the surface and the desired π0 was attained by changing 
the amount of lipid applied to the air-water interface. For allowing incorporation into 
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the monolayer, peptides were injected into the aqueous subphase with a Hamilton 
microsyringe. 
 
2.3 Vesicle permeability assays – ER-like large unilamellar vesicles (LUV) were 
prepared according to the extrusion method [24]. Vesicle permeabilization was assayed 
by monitoring the release to the medium of encapsulated fluorescent ANTS (ANTS-
DPX assay) [25]. LUV containing 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl and 5 
mM Hepes were obtained by separating the unencapsulated material by gel-filtration in 
a Sephadex G-75 column that was eluted with 5 mM Hepes and 100 mM NaCl (pH 
7.4). Internal and external osmolarities were measured in a cryoscopic osmometer 
(Osmomat 030, Gonotec, Berlin, Germany) and adjusted by adding NaCl. Fluorescence 
measurements were performed in an SLM Aminco 8100 spectrofluorimeter (Spectronic 
Instruments, Rochester, NY) by setting the ANTS emission at 520 nm and the 
excitation at 355 nm. A cutoff filter (470 nm) was placed between the sample and the 
emission monochromator. The baseline leakage (0%) corresponded to the fluorescence 
of the vesicles at time 0, while 100% leakage was the fluorescence value obtained after 
addition of Triton X-100 (0.5% v/v). 
2.4 Planar lipid membranes formation –. Two monolayers were made from 5 mg/ml 
pentane solutions of lipid mixture buffered with 5 mM NaOAc with 150 mM KCl at 
both sides of Teflon chambers partitioned by a 15 m thick Teflon film with 70-100 m 
diameter orifices. Planar lipid bilayers were formed by monolayer apposition on the 
orifices previously treated with a 1% solution of hexadecane in pentane. Protein and 
peptides dissolved in DMSO were supplemented to the lipid solutions prior to 
monolayer formation only in one of the chamber sides, the cis side. Bilayer formation 
was directly detected and its thickness can be estimated by capacitance measurements. 
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2.5 Channel conductance measurements – An electric potential was applied using 
Ag/AgCl electrodes in 2 M KCl, 1.5% agarose bridges assembled within standard 250 
µl pipette tips. Potential is defined as positive when it is higher at the side of the protein 
addition (the cis side), while the trans side is set to ground. An Axopatch 200B 
ampliﬁer (Molecular Devices, Sunnyvale, CA) in the voltage-clamp mode was used for 
measuring the current and applying potential. The membrane chamber and the head 
stage were isolated from external noise sources with a double metal screen (Amuneal 
Manufacturing Corp., Philadelphia, PA). For each sample, at least 50 different traces 
were typically recorded (recording time for each trace was 200 s). 
A rough first estimation of pore diameter considered a cylindrical neutral pore. Thus, 
channel conductance G can be written in terms of solution conductivity , and pore 
dimensions, according to the following equation:  
2
4


D
G
L
     (1) 
 where L and D stand for length and diameter, respectively. 
2.6 Single vesicle permeabilization –.For the single vesicle approach, Giant 
Unilamellar Vesicles (GUVs) made of PC:PE:PI:Rho-PE (50:30:20:0.1 mole ratio) 
were prepared according to the electroformation method as described in previous works 
[26, 27]. Confocal fluorescence microscopy images of individual GUVs were obtained 
in a commercial Nikon D Eclipse TE2000-U fluorescence microscope (Nikon 
Instruments, Tokyo, Japan). Image processing and analyses were carried out with 
ImageJ (rsb.info.nih.gov/ij/). Extents of permeabilization were calculated after 
incubation with Alexa Fluor 488 and 0.2 μM of p7 peptides from the ratio of 
fluorescence intensity inside and outside each vesicle. Exposure of GUVs to peptide for 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 8 
 
30 min or 2 hours rendered essentially the same proportion of vesicles permeabilized, 
and the same levels of permeabilization per vesicle, therefore indicating that the system 
was at equilibrium at the times selected for performing the measurements (usually 30 
min). 
 
2.7 Cell expression of recombinant p7 –.For cell expression of GFP-p7 fusion 
proteins, 293T cells (2 x 10
5
 cells) were co-transfected with plasmids encoding GFP-p7 
fusions and mCh-Sec61 beta (1 µg each) using calcium phosphate [17]. Under these 
conditions 70-80% of the cells in the culture were successfully transfected. At 36 h 
post-transfection, cells were fixed with 4% formaldehyde in phosphate saline buffer 
(PBS) and incubated with Hoechst dye.  Confocal images were acquired on a Leica 
TCS SP5 II microscope (Leica Microsystems GmbH, Wetzlar, Germany), using a x63 
water-immersion objective. For the oligomerization assays, 293T cells (1.5 x 10
6
 cells) 
were transfected with 10 µg of plasmid encoding GFP-p7 constructs. At 36 h post-
transfection, cells were collected in cold PBS, sonicated for 1 min on ice with a probe 
tip sonicator (MSE Soniprep 150, MSE, UK) and dissolved in SDS-PAGE loading 
buffer. Oligomers were detected by immunoblot analysis using anti-GFP antibody. 
 
2.8 Construction of CSFV mutants –. A full-length infectious clone of the virulent 
Brescia strain (pBIC) [28] was used as a template to obtain all cDNA as described [18]. 
pBICv-p7-KK (p7 residues 
39
KK
40
 to EE) and pBICv-p7-FH (p7 residues 
46
FH
47
 to 
AA) constructs containing desired mutations in the genomic area encoding for p7 
protein were obtained using the QuickChange XL Site-Directed Mutagenesis kit 
(Stratagene, San Diego, CA). Presence of virus infected cells was detected by 
immunoperoxidase staining utilizing the CSFV monoclonal antibody WH303 (mAb 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 9 
 
WH303) [29] and the Vectastain ABC kit (Vector Laboratories, Burlingame, CA).  
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3.Results  
 
3.1 Effect of mutations on monolayer penetration and LUV permeabilization by 
p7C 
The pore-forming domain of CSFV p7 encompasses a transmembrane helix 
(hydrophobic region 41-67), and the preceding cytosolic loop containing a polar stretch 
(residues 33-40) [18, 19] (Fig. 1A). In previous work, alignment of p7 employing 37 
pestivirus sequences, including those derived from 24 CSFV isolates, highlighted the 
strict conservation of residues Lys39/Lys40 and Phe-46/His47 [18]. These dipeptides 
are located within the cytosolic loop and on the hydrophilic face of the pore helix, 
respectively [18]. Here, we have aimed at elucidating the role of those invariant 
residues in the pore formation and ion-channel function of p7C-wt, by substituting both 
Lys39/Lys40 residues to Glu (p7C-KK), and by substituting Phe-46/His47 both with 
alanines (p7C-FH) (Fig. 1A).  
The Figure 1B compares capacities of p7C-wt, p7C-FH and p7C-KK peptides for 
inserting into ER-like membrane monolayers composed of PC:PE:PI (5:3:2 molar 
ratio). To estimate penetration capacities, we determined the critical pressures (πc-s) for 
insertion, obtained by extrapolation to i = 0 (i.e., the surface pressures at which the 
sequences were excluded from the lipid monolayer) [30]. The parental, p7C-wt, and the 
p7C-FH mutant were capable of penetrating into ER-like monolayers above surface 
pressures of unstressed natural membranes (πc ≥ 30 mN/m, [31]). In sharp contrast, the 
πc measured for the p7C-KK mutant, ca. 27 mN/m, was below that value, thereby 
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suggesting a lower capacity to integrate as a component of the membrane monolayer. 
Moreover, the lower slope observed in this latter sample for the increase in pressure as a 
function of π0, suggests that reduced amounts of peptide could associate with the 
monolayer.  
Comparison of ER-LUV permeabilization (ANTS/DPX release assay) induced by the 
three p7 peptides is shown in Figure 1C. The parental sequence p7C-wt and the mutant 
p7C-FH displayed comparable capacities for permeabilizing ER-like liposomes. 
Consistent with its incapacity for insertion, the p7C-KK peptide showed marginal 
activity in the ANTS/DPX assay. Thus, overall, results displayed in Figure 1 
established a clear distinction between p7-wt and p7-FH in the one hand, and p7-KK on 
the other, regarding insertion and permeabilization of ER-like membranes. However, 
bulk permeability measured with the ANTS/DPX assay did not reveal differences 
between p7-wt and p7-FH mutant. 
 
3.2 Effect of mutations on ion-channel activity of p7C 
To complement bulk permeability measurements, we next carried out a comparative 
characterization of IC activity of p7C and derived mutants (Fig 2). Electrophysiological 
recordings, as those displayed in Figure 2A, demonstrated that each substitution 
distinctively affected the IC activity measured in ER-like planar bilayers. IC activity of 
p7C-wt was characterized by “opening” and “closing” events between close current 
levels (6 ± 1 pA), and occasional jumps to large current levels (> 50 pA). In contrast, 
p7C-FH exhibited the small changes in conductance (5 ± 1 pA), but large current levels 
were hardly observed (see also recordings in Fig 2B displayed with a different intensity 
scale). The statistical analyses of the observed conductance levels displayed on Figure 
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2C illustrate this point further. Thus, the FH x AA substitution specifically suppressed 
the high-conductance levels. Finally, IC activity was mostly absent in samples 
containing the p7C-KK peptide, consistently with the limited membrane insertion 
detected in the monolayer experiments (Fig. 1B).  
The small jumps observed in both, p7C-wt and p7C-FH samples, correspond to channel 
currents of conductance in the range G = 120-300 pS at the applied voltage (50 mV). 
Assuming a cylindrical geometry (see Material and Methods), such conductance levels 
can be attributed to channels with diameters in the range of d ~ 0.5 -1 nm. Thus, these 
pore structures were wide enough to allow release of solutes with the size of the 
ANTS/DPX fluorescent probe/quencher pair (assumed diameters of 5-8 Å) [32]. 
Accordingly, p7C-wt and p7C-FH induced comparable levels of ANTS/DPX release 
from vesicles (see previous Fig 1C).  
The origin of the large current levels that are distinctive of the p7C-wt peptide is 
more difficult to trace. In principle, the electrophysiological experiments do not allow 
categorical discrimination between two possibilities, namely, the simultaneous opening 
of several concatenated channels with similar sizes, or the formation of a wider, single-
type of channel structure [33, 34]. In the latter case, given that currents between 100 
and 350 pA in Figure 2C correspond to conductance values in the range G = 2-7 nS, the 
estimated channel diameters would span up to d  5 nm. Interestingly, the existence of 
such wide channels could be probed in permeability experiments involving solutes of 
Stokes’ radius between 1 and 3 nm (see below). 
 
3.3 Activity of the p7 porating domain assayed in single ER-GUVs 
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To gain insight into the different mechanisms of permeabilization by the wt and 
mutant p7 peptides, we complemented ion-channel measurements with a single-vesicle 
approach based on the use of ER-GUVs (Figs 3 and 4). The confocal micrographs 
depicted in Figure 3A illustrate the fundamentals of the ER-GUV permeabilization 
assay. In the general views (top panels), untreated ER-GUVs (CTL), or those treated 
with p7N peptide representing the N-terminal portion of the viroporin p7 [19], are 
viewed as dark (empty) spheres surrounded by the orange-labeled lipid bilayer, against 
a green background containing the permeant Alexa Fluor 488 dye. Incubation with the 
pore-domain peptide p7C-wt gives rise to green labeling of the internal ER-GUV 
compartments (arrows), indicating permeabilization of the lipid bilayer to the dye. By 
analyzing the balance of fluorescence intensity inside and outside the intact vesicles, 
one can infer the degree of permeabilization (percentage) for a single ER-GUV (bottom 
panels). Although in the p7C-wt sample the majority of permeabilized vesicles 
approached 100 % permeabilization (right), some of the vesicles still showed partial 
filling at equilibrium (center). Whereas total membrane permeabilization occurs 
through stably assembled pore structures, the partial permeabilization observed in these 
systems at equilibrium is usually ascribed to the transient destabilization that may occur 
coupled to peptide insertion.  
The quantitative analysis shown in Figure 3B reflects the relative importance of each 
phenomenon. In those experiments the filling degree of individual ER-GUVs was 
measured at equilibrium after treatment with p7N or p7C-wt peptides. Consistent with 
prior ANTS/DPX assays and ion-conductance measurements [20], only p7C-wt 
incubated at pH 5.0, but not at neutral pH, induced entry of the dye into vesicles, which 
otherwise maintained their integrity during the process. Finally, peptides bearing the 
point mutations p7C-KK and p7C-FH reproduced the behavior observed in bulk 
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ANTS/DPX assays, i.e., no activity in the former case, whereas the activity of the latter 
was indistinguishable from that of p7C-wt (Fig 3C).  
The ER-GUV approach further allowed assessing the formation of pores with distinct 
dimensions. To that end degrees of vesicle permeabilization were quantitatively 
determined as a function of the permeative solute size (Fig. 4). Micrographs displayed 
in Figure 4A compare the observed differences in the filling degree of vesicles when 
FITC-labeled fluorescent dextrans of 4 or 70 kDa were used to estimate degrees of p7C-
wt-induced permeabilization (left and right panels, respectively). The micrographs 
reveal entry of the low molecular-weight 4kDa dextran (left panels), whereas the larger 
70 kDa marker remains outside the vesicles (right panels). 
A more detailed quantitative comparison is presented in Figure 4B. Most vesicles 
treated with p7C-wt were totally permeabilized to 4, 10 and 20 kDa dextrans, whereas a 
significant reduction in the number of totally permeabilized vesicles was observed for 
the 70 kDa permeant solute. By comparison, partial permeabilization was overall lower 
for solutes of all sizes. In contrast, reduction of the total permeabilization levels was 
already observed for smaller solutes (10 kDa) in the case of the p7C-FH, which 
resembled in other aspects the wt sequence. As expected, p7C-KK did not show 
permeabilizing activity for any solute in these assays (not shown).  
This point is further illustrated in Figure 4C that compares the percentage of vesicles 
displaying stable (filling degree>70%) and transient (filling degree: 20-70%) pores 
(total and partial permeabilization, respectively). Decrease of the total permeabilization 
levels is observed for the 70 and 4 kDa dextrans in p7C-wt and p7C-FH samples, 
respectively (left panel). The right panel displays the percentage of vesicles partially 
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filled (20-70 % permeabilization range). The percentages are in both samples 
comparable and less significant, and do not seem to depend on the solute size.  
In conclusion, the p7C-wt-induced ER-GUV permeabilization appears to evolve 
primarily mediated by stable pores allowing diffusion of solutes as large as 20 kDa 
(approximate Stokes’ radius of 3.3 nm). This verifies the existence of large pores with 
diameters of several nanometers as hypothesized in the discussion of Fig 2C (see 
above). By comparison, the stable pores formed by the peptide bearing the FH x AA 
mutation seem to be narrower, allowing free diffusion of Alexa Fluor 488 (approximate 
Stokes’ radius of 0.6 nm), limited diffusion of 4kDa dextrans (approximate Stokes’ 
radius of 1.4 nm), and no diffusion of the larger permeative solutes.  
 
3.4 Effect of mutations on the distribution/oligomerization of p7 in transfected 
cells and on virus production 
To establish the biological relevance of the studied mutations, we first determined 
whether they affected the biogenesis and assembly of p7 within the ER (Fig. 5A-C). 
Confocal microscopy of cells transfected with each of the GFP-p7 constructs was 
conducted to establish the cell localization of the protein upon synthesis (Fig 5A, B). 
Expression of the GFP control (i.e., devoid of the membrane anchors) revealed 
homogeneous cell labeling, including the presence of the fluorescent marker in the 
nucleus (Fig 5A, top, green label). This was in contrast to the sole labeling of the ER 
compartment by mCh-Sec61 (Fig 5A, top, red label). Consistent with previously 
reported data [22], the wild-type construct GFP-p7 co-localized with the ER marker 
(see also Fig 5B). The FH x AA mutation in the pore domain did not alter significantly 
the distribution of the protein. Finally, confocal images of the protein bearing the KK x 
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EE mutation at the cytosolic loop revealed a more diffuse intracellular fluorescent 
labeling, a pattern resembling cells expressing the GFP control. Accordingly, this latter 
construct did not co-localize significantly with mCh-Sec61 (Fig 5B). 
To test the oligomeric state of the expressed proteins, SDS-PAGE analyses were 
subsequently performed on extracts of the transfected cells (Fig 5C). Immunoblots 
probed with the anti-GFP antibody showed bands consistent with the formation of high-
order homo-oligomers in cells expressing the GFP-p7 and GF -p7-FH constructs 
(arrow). Even though a band consistent with the formation of homo-oligomers was also 
found in cells expressing the GFP-p7-KK construct, the band corresponding to the 
higher-order homo-oligomers was absent in these samples. From the results displayed 
in Figures 5A-C the following conclusion can be drawn: whereas the FH x AA 
mutation does not alter the biogenesis of the viroporin p7, the KK x EE mutation 
appears to interfere with insertion into the ER membrane and oligomerization therein.  
Finally, to evaluate the effect of the amino acid substitutions 
39
KK
40
-EE and 
46
FH
47
-
AA in the replication of CSFV, two recombinant CSF viruses containing the 
corresponding amino acid substitutions in the pore-forming domain of p7 were 
produced using the cDNA infectious clone of the Brescia strain (BICv) as a template. 
Mutated cDNA infectious clones pBICv-p7-KK and pBICv-p7-FH were developed by 
site directed mutagenesis. 
Infectious RNA was in vitro transcribed from each mutated full-length cDNA and 
used to transfect SK6 cells [18]. Infectious virus was rescued from transfected cells by 
day 4 post-transfection using the pBIC construct encoding for the parental virus BIC 
with titers reaching almost 10
7
 TCID50/ml. In contrast, after four independent 
transfection procedures, pBICv-p7-KK and pBICv-p7-FH constructs did not produce 
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infectious viruses. Real-time RT-PCR analysis of total RNA extracted from cells 
transfected with pBICv-p7-KK and pBICv-p7-FH constructs revealed genomic RNA 
replication, (data not shown). In addition, immunohistochemistry analysis of transfected 
cell monolayers was performed using a monoclonal antibody recognizing CSFV 
structural glycoprotein E2 (Fig. 5D). As expected, cell monolayers transfected with 
pBIC-p7 showed a large number of cells expressing massive levels of E2 (right-most 
panel). Conversely, pBICv-p7-FH transfected cells showed the presence of small and 
isolated foci of cells expressing structural glycoprotein E2, while there was a complete 
absence of E2 expression in cells transfected with pBICv-p7-KK construct (mid 
panels). Attempts to rescue infective virus from cell cultures transfected with either 
pBICv-p7-KK or pBICv-p7-FH were performed by four successive blind passages in 
fresh monolayers of SK6 cells. No infectious virus could be detected in any of the four 
passages for either of the constructs tested. Therefore, residues 
46
FH
47
 and 
39
KK
40
 in the 
pore-forming domain of p7 appear to be critical for CSFV replication. 
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4. Discussion 
ER permeabilization is a pivotal event required for the progression of the cell 
replication cycle of many viruses [15, 17]. The CSFV p7 product has been shown to 
permeabilize ER-like membranes following a lipid-dependent pattern [18, 19], and to 
localize in the ER upon expression [22], and hence constitutes an optimal model to 
study this phenomenon. Following strategies described previously [33, 35], in a 
preceding work we established a minimal channel structure represented by p7C-wt [19]. 
Those studies pinpointed the polar, cytosolic loop 
33
MRDEPIKK
40
, as a regulatory 
element that conferred pH and inhibitor sensitivity to the pore, and the C-terminal helix 
41
WILLLFHAMTNNPVKTITVALLMVSGV
67
 as the actual pore-forming domain. The 
p7C-wt peptide combined both elements and was simultaneously competent in 
conducting ions across lipid bilayers mimicking the ER, and in allowing release of 
small solutes (ANTS/DPX) from ER-LUVs [20]. Motivated by the observation that the 
invariant residues 
39
KK
40
 and 
46
FH
47
 were located within these functional regions [18], 
we sought to analyze the effect of non-conservative KK x EE and FH x AA double 
substitutions on the pore-forming activity of p7C-wt. 
Since the cytosolic loop invests the pore domain of p7 with sensitivity to pH and 
inhibitors [19, 20], we expected assembly of less regulated pores in membranes be the 
consequence of substituting the conserved Lys39-Lys40 residues by the negatively 
charged Glu-Glu dipeptide. However, contrary to our expectations, incorporating the 
KK x EE mutation in the p7C-KK peptide resulted in defective monolayer penetration 
and absence of membrane permeabilization (Figs 1-4). These findings suggest that the 
loop not only regulates permeability but also conditions insertion into ER membranes. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 19 
 
In consonance with this limiting defect, the same mutation resulted in an anomalous 
distribution and defective homo-oligomerization of p7 upon cell expression (Fig. 5A-
C). Interestingly, the suppressing effect of a cognate mutation in HCV p7 has been 
related to alterations in membrane-topology [36]. From molecular dynamics 
simulations, it was inferred that the basic residues sitting in the membrane interface 
could engage electrostatic interactions with negatively charged lipid polar head groups 
to properly orient the TM helices [33, 37]. Thus, we infer that perturbing the set of 
interactions between basic Lys-Lys residues and negatively charged PI at the membrane 
interface, may also result in the inefficient insertion/pore-formation of CSFV p7. 
Finally, highlighting the crucial role of pore-forming p7 protein in the CSFV replication 
cycle, the KK x EE mutation also suppressed production of infectious virus (Fig 5D), 
an observation in line with previous results obtained for p7 of the BVDV pestivirus [38] 
and our own Ala-scanning mutagenesis [18].  
In contrast, the p7C-FH peptide, displayed less capacity for inserting into monolayers 
than p7C-wt, but retained the membrane-permeabilizing capacity of the parental 
sequence measured in ANTS/DPX-LUV assays (Fig. 1). However, complementation of 
these bulk measurements with IC activity and single ER-GUV permeability 
determinations revealed functional differences between both sequences (Figs. 2-4). 
Electrophysiogical recordings disclosed two distinct phenotypic traits: co-existence of 
small and large conductance channels in p7C-wt, and predominance of small apertures 
in the p7C-FH. Similarly, single-channel recordings of Hepatitis C virus p7 protein by 
the patch clamp technique revealed distinct conductance values of 35, 57, 120, and 184 
pS [33]. It was argued that large conductance levels could represent either insertion of 
simultaneous channels, or an increase in the number of p7 monomers per channel and 
hence, a wider current passage. Under our measuring conditions, we observe 
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comparable conductance levels of 120 pS for both p7C-wt and p7C-FH, which would 
be compatible with channel sizes allowing release of ANTS/DPX, explaining the 
similar porating capacities observed in the LUV-based assay. However, in the case of 
the p7C-wt peptide, these structures co-existed with channels giving rise to higher 
conductance (> 1 nS) whose origin was uncertain.  
To address the origin of the different stages observed in the membrane 
permeabilization induced by p7C-wt, the process was imaged at the individual vesicle 
level by fluorescence microscopy of ER-GUVs (Figs 3 and 4). These objects attain cell 
dimensions and, when applied to permeability assays, the single GUV approach offers 
several advantages as compared to measurements in bulk (i.e., LUV-based ANTS/DPX 
assays). Firstly, owing to the fluorescent lipid label, their surrounding lipid bilayer can 
be readily observed by confocal microscopy, which allows monitoring its overall 
stability upon treatment with the permeabilizing agent, i.e., one can discern membrane 
permeabilization through discrete pores vs. lipid bilayer disaggregation by detergent-
like mechanisms [3, 10]. Secondly, GUV membranes can be considered as flat planes 
devoid of curvature stress, i.e., they mimic the conditions of the planar bilayers used in 
electrophysiological experiments more closely than LUVs. And thirdly, one can discern 
solute-encapsulation heterogeneities that may arise in the population of permeabilized 
vesicles, which go unnoticed in bulk measurements [26].  
Explicitly, in the case of totally permeabilized GUVs, the open state of the pore lasts 
enough as to allow the equilibration of the probe with the external medium. Both, p7C-
wt and p7C-FH permeabilized ER-GUVs to alexa-488 and 4 kDa-dextran according to 
this mechanism (Fig. 4B). However, the number of totally permeabilized ER-GUVs 
dropped for larger dextrans in the case of p7C-FH, but not in the case of p7C-wt (Fig. 
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4C). This observation suggests that stably opened pores of larger dimensions were only 
accessible to the wt sequence. On the other hand, the partial permeabilization process 
seems to be related to transient membrane lesions of the bilayer permeability that do not 
allow rapid equilibration with the external solution. The fact that the number of ER-
GUVs partially permeabilized was marginal in the p7C-wt and p7C-FH samples (Fig 
4C), underscores the prevalent role of stable channel-pore structures in mediating IC 
activity and dye influx into GUVs. 
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5. Conclusions 
In conclusion, our IC activity and GUV permeabilization data provide a clear 
demonstration for assembling channel-pores with distinct aperture widths by the 
porating domain of p7 CSFV in ER-mimicking membranes. To our best knowledge, 
this is the first time that electrophysiological and single-vesicle approaches are 
combined to solve the permeabilization mechanism of a pore-forming product 
functioning in the context of ER membranes. Notably, the FH x AA mutation favoring 
small-size pores abrogated virus production without altering the cell distribution or 
oligomerization degree of p7 upon expression (Fig. 5). Further research efforts will be 
required to get insight into the distinct physiological roles of the p7C capacity to form 
pores of different dimensions, and we foresee that the FH x AA mutation described in 
this work may provide a useful tool in the context of cell infection by pestiviruses. It is 
tempting to speculate that manipulating pore-forming function of p7 by mutagenesis 
may provide in the future new approaches to vaccine and anti-viral development to treat 
pestivirus infections. 
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Figure captions 
Fig 1: Effects of mutations on p7C insertion into membranes and LUV 
permeabilization. A) Designation and sequences of CSFV p7 peptides used in the 
analysis. The ribbon and helix displayed below span the sequences of the polar 
cytosolic loop and the C-terminal transmembrane helix of p7, respectively. B) Insertion 
into ER-like lipid monolayers. Maximum increase in surface pressure induced by p7C-
wt, p7C-FH or p7C-KK peptides (black, blue and red, respectively), measured as a 
function of the initial surface pressure of the phospholipid monolayer. he dotted line at 
30 mN/m marks the pressure of an unstressed membrane. The critical pressures for 
insertion (c-s) of each peptide are indicated in the panel. C) Comparison of leakage 
levels induced by increasing peptide doses in the ANTS/DPX assay. The plotted values 
correspond to extents of leakage measured 200 s after p7C-wt, p7C-FH or p7C-KK 
peptide addition to ER-LUVs (black, blue and red, respectively). 
Fig 2: Effects of p7 mutations on ion-channel activity A) Typical current recordings 
measured in 150 mM KCl, pH 5.0 at a potential of -50 mV, after the addition of p7C-wt, 
p7C-FH or p7C-KK to ER-like lipid bilayers. B) To illustrate the different magnitude of 
current levels seen in the experiments, traces of the p7C-wt and p7C-FH ion channel 
activity have been displayed with a different intensity scale. C) Histograms of the 
current levels recorded for p7C-wt and p7C-FH (left and right panels, respectively).  
Fig 3: Single ER-GUV permeabilization induced by p7 peptides. A) Top: 
micrographs depict Rho-PE-labeled ER-GUVs (orange circumferences) immersed in a 
solution containing Alexa Fluor 488 (green background). Samples correspond to control-
untreated ER-GUVs (left), or ER-GUVs treated with p7N or p7C-wt (center and right 
panels, respectively). The red arrows point to permeabilized vesicles in the latter sample. 
Bottom: single ER-GUVs treated with p7C-wt displaying different levels of 
permeabilization to Alexa Fluor 488. B) Distribution of ER-GUVs according to their 
permeabilization level after treatment with p7N or p7C-wt at pH 5.0, or p7C-wt at pH 
7.4. C) Effect of the mutations on permeabilization of the ER-GUVs measured at pH 5.0. 
Horizontal scales in panels B and C, chosen arbitrarily to show the distribution of points. 
Fig 4: ER-GUV permeabilization as a function of the solute size. A) Micrographs 
compare p7C-wt-induced permeabilization to dextrans of 4 and 70 kDa (left and right 
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panels, respectively). B) ER-GUV distribution according to the percentage of 
permeabilization per vesicle. Samples were treated with the p7 peptides as indicated in 
the panels, and percentages of entry in single vesicles calculated for the different solutes. 
C) Percentages of vesicles permeabilized via stable or transient pores as a function of the 
solute size (left and right panels, respectively). The threshold by which permeabilized 
GUVs (>20% filling) were considered as totally (filling degree >70%) or partially 
(filling degree <70%) permeabilized was chosen attending to the data-point distribution. 
 
Fig 5: Effects of the mutations on the distribution/oligomerization state of 
recombinant p7 within cells and on virus production. A) Distribution of p7 and its 
mutants by confocal microscopy. The cells co-transfected with GFP-p7 constructs and 
the ER marker mCh-Sec61 were fixed and stained with Hoechst. The panels depict 
examples of individual cells co-expressing GFP constructs and mCh-Sec61. Scalebars 
represent 10 µm.  The control GFP devoid of membrane anchors labelled the complete 
cell (top panel). GFP-p7 and GFP-p7-FH were excluded from the nucleus and co-
localized with mCh-Sec61 (mid top and bottom panels, respectively). GFP-p7-KK 
(bottom panel), produced a pattern comparable to that obtained after expression of GFP 
control. B) Co-localization of mCh-Sec6 and GFP in the samples as calculated with the 
ImageJ plugin Coloc 2 program (http://imagej.net/Coloc_2). Measurements were carried 
out in at least 6 cells as those displayed in the previous panel. Bars represent mean 
values ± SE. C) Homo-oligomerization in cells transfected with the GFP constructs. Cell 
extracts were applied to SDS-PAGE and GFP detected using Western blotting. The 
arrow marks the band corresponding to high-order homo-oligomers. D) CSFV protein 
expression in SK6 cultures transfected with infectious clones encoding for p7 mutants 
and parental BICv. Detection of CSFV E2 protein was done by immunocytochemistry in 
SK6 cells transfected with recombinant constructs pBICv-p7-KK and pBICv-p7-FH. 
SK6 cells were transfected with either mutant construct or with infectious clone 
encoding for parental wild type virus (pBIC-p7). Four days after transfection monolayers 
were ethanol:acetone fixed and stained with monoclonal antibody WH303 which 
specifically recognize CSFV structural glycoprotein E2. 
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Highlights:  
 
- We have analyzed ion-channel activity and single GUV permeabilization by CSFV p7 
- The data support the formation of p7 pores with approximate diameters of 1 and 5 nm 
- A mutation results in loss of large ion-conducting channels and restricted pore size  
- Manipulation of p7 pores may provide new strategies to attenuate pestivirus particles  
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